What key MRI problems does ACDx address?
Reliable, high quality images, streamlined workflow and patient safety monitoring are our key objectives. Multiple artifacts, including gradients, magneto hydrodynamic effect and body motion, impair MR image quality, workflow and patient safety monitoring.
How does ACDx differ from other Gating & Monitoring systems regarding artifacts?
Most Gating & Monitoring systems use multiple filters to isolate the ECG R-wave, as the trigger point for synchronizing imaging. At high magnet strengths, filter-generated offsets and jitter impair the already increased artifact impacts, affecting image quality and synchronization accuracy.
ACDx uses a proprietary, non-filter based approach to acquire signals at a very high resolution and accurately separate artifact and clinically useful signals (e.g. ECG, blood-flow). This capability provides precision triggering, improved image quality and diagnostic quality patient safety ECG monitoring.
Does ACDx look or operate differently compared to other Gating & Monitoring solutions?
Yes and No. Physically, ACDx looks and feels the same. Logically, it does not require user intervention to change filter settings and facilitates flexible trigger points across the entire ECG cycle.
Is ECG lead placement limited as with other Gating & Monitoring systems?
Lead placement and spacing are mostly constrained by gradient and MHE artifacts. Since ACDx removes these an other artifacts, lead placement and spacing can significantly increased.
Is ACDx's architecture the same as leading competitive products?
ACDx has a modular design to meet both fundamental and specialized requirements.
Its Base Platform will provide Precision Gating & Flexible Triggering as well as real-time Heart-rate Variability.
It also provides add-on modules for:
How does ACDx benefit the MRI industry?
Besides helping to ensure more reliable and clearer images, ACDx will deliver several ECG configurations, including 12-lead, to monitor patients with diagnostic quality. This allows flexibility to monitor during specific tests: cardiac stress for ischemia, electrical mapping for arrhythmia, MR-based interventional guidance, stroke, etc.
Does ACDx utilize AI in any way?
Yes, as a machine learning process to continually improve on ACDx's advanced algorithms and, eventually, as a method for correlating images and physiological data with demographics, evidenced-based practice and other decision-support data.
Will All Clear Diagnostics publish peer-reviewed papers on its data validation results, prior to product launch?
Yes. It may publish data validation reports prior to clinical trials and peer-review publication after trials, prior to product launch.
Do you have a newsletter. How often is it distributed.
At this point, during development phases, we will not be distributing a newsletter.
However, once we enter Field Validation Testing and through market launch, our newsletter will be published on a quarterly basis or when we have something juicy to share.
To sign up for our Newsletter, please click the button below.
Do you have a question for All Clear Diagnostics? If so, click on this link to send us your question.